Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial

NCT01216982 is registered in ClinicalTrials.gov with United States Department of Defense as lead sponsor.

NCT NCT01216982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01216982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial
Lead sponsor
United States Department of Defense
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2010
Completion date
June 30, 2011
Enrollment
256 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combat disorders, depression, mood disorders, stress disorders